Cancellation of state registration. Dopamine hydrochloride

February 06, 2018
Active substances:
ICD-10:
IX.I30-I52.I50.1    Left ventricular failure
XVIII.R50-R69.R57.0    Cardiogenic shock
XVIII.R50-R69.R57.1    Hypovolemic shock
XVIII.R50-R69.R57.8    Other types of shock
XIX.T66-T78.T78.2    Anaphylactic shock, unspecified
XIX.T79.T79.4    Traumatic shock
Dopamine, shock, hypovolemic shock, anaphylactic shock, cardiogenic shock, acute heart failure

Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish the state registration and exclusion from the state register of medicines for the medical use of the medicinal product (registration certificate P N015579 / 01 dated 14.05.2009 issued by Warsaw Pharmaceutical Factory Polfa, Poland ):

Dopamine hydrochloride (trade name of the medicinal product)

Dopamine (international non-proprietary or grouping or chemical name)

Concentrate for solution for infusion, 10 mg / ml, 40 mg / ml (dosage form, dosage)

Warsaw Pharmaceutical Factory Polfa, Poland 22/24, Karolkowa Str., 01-207, Warsaw, Poland (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing an application by the authorized legal entity of JSC AKRIKHIN to abolish the state registration of the medicinal product.